Annual CFO
$156.12 M
+$379.68 M+169.83%
31 December 2023
Summary:
Exact Sciences annual cash flow from operations is currently $156.12 million, with the most recent change of +$379.68 million (+169.83%) on 31 December 2023. During the last 3 years, it has risen by +$258.36 million (+252.70%). EXAS annual CFO is now at all-time high.EXAS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$138.72 M
+$31.65 M+29.57%
30 September 2024
Summary:
Exact Sciences quarterly cash flow from operations is currently $138.72 million, with the most recent change of +$31.65 million (+29.57%) on 30 September 2024. Over the past year, it has increased by +$69.17 million (+99.46%). EXAS quarterly CFO is now at all-time high.EXAS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$233.02 M
+$114.36 M+96.37%
30 September 2024
Summary:
Exact Sciences TTM cash flow from operations is currently $233.02 million, with the most recent change of +$114.36 million (+96.37%) on 30 September 2024. Over the past year, it has increased by +$76.90 million (+49.26%). EXAS TTM CFO is now at all-time high.EXAS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +99.5% | +49.3% |
| 3 y3 years | +252.7% | +664.5% | +327.9% |
| 5 y5 years | +239.8% | +648.3% | +308.7% |
EXAS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +169.8% | at high | +179.8% | at high | +177.6% |
| 5 y | 5 years | at high | +169.8% | at high | +179.8% | at high | +177.6% |
| alltime | all time | at high | +169.8% | at high | +179.8% | at high | +177.6% |
Exact Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $138.72 M(+29.6%) | $233.02 M(+96.4%) |
| June 2024 | - | $107.06 M(-230.1%) | $118.66 M(+5.9%) |
| Mar 2024 | - | -$82.31 M(-218.3%) | $112.02 M(-28.2%) |
| Dec 2023 | $156.12 M(-169.8%) | $69.55 M(+185.5%) | $156.12 M(+12.6%) |
| Sept 2023 | - | $24.36 M(-75.7%) | $138.61 M(+89.0%) |
| June 2023 | - | $100.42 M(-362.8%) | $73.32 M(-183.3%) |
| Mar 2023 | - | -$38.22 M(-173.4%) | -$88.02 M(-60.6%) |
| Dec 2022 | -$223.56 M(+118.7%) | $52.04 M(-227.1%) | -$223.56 M(-25.5%) |
| Sept 2022 | - | -$40.93 M(-32.8%) | -$300.17 M(+0.1%) |
| June 2022 | - | -$60.92 M(-64.9%) | -$300.02 M(+50.9%) |
| Mar 2022 | - | -$173.75 M(+607.1%) | -$198.76 M(+94.4%) |
| Dec 2021 | -$102.24 M(-174.9%) | -$24.57 M(-39.7%) | -$102.24 M(-403.0%) |
| Sept 2021 | - | -$40.77 M(-201.1%) | $33.74 M(-78.4%) |
| June 2021 | - | $40.34 M(-152.2%) | $156.29 M(+43.3%) |
| Mar 2021 | - | -$77.23 M(-169.3%) | $109.08 M(-20.1%) |
| Dec 2020 | $136.48 M(-222.2%) | $111.40 M(+36.2%) | $136.48 M(<-9900.0%) |
| Sept 2020 | - | $81.78 M(-1290.3%) | -$223.00 K(-99.8%) |
| June 2020 | - | -$6.87 M(-86.2%) | -$111.14 M(+27.3%) |
| Mar 2020 | - | -$49.83 M(+96.9%) | -$87.33 M(-21.8%) |
| Dec 2019 | -$111.66 M(+62.0%) | -$25.30 M(-13.2%) | -$111.66 M(+28.0%) |
| Sept 2019 | - | -$29.15 M(-272.0%) | -$87.20 M(+40.4%) |
| June 2019 | - | $16.95 M(-122.9%) | -$62.11 M(-40.6%) |
| Mar 2019 | - | -$74.15 M(+8613.7%) | -$104.57 M(+51.7%) |
| Dec 2018 | -$68.94 M(-3.9%) | -$851.00 K(-79.0%) | -$68.94 M(+0.1%) |
| Sept 2018 | - | -$4.05 M(-84.1%) | -$68.85 M(-2.0%) |
| June 2018 | - | -$25.51 M(-33.8%) | -$70.25 M(-8.3%) |
| Mar 2018 | - | -$38.52 M(+4942.1%) | -$76.61 M(+6.8%) |
| Dec 2017 | -$71.72 M(-44.9%) | -$764.00 K(-86.0%) | -$71.72 M(-26.9%) |
| Sept 2017 | - | -$5.45 M(-82.9%) | -$98.09 M(-16.6%) |
| June 2017 | - | -$31.87 M(-5.3%) | -$117.61 M(-3.1%) |
| Mar 2017 | - | -$33.64 M(+24.0%) | -$121.36 M(-6.7%) |
| Dec 2016 | -$130.07 M(-2.9%) | -$27.13 M(+8.7%) | -$130.07 M(-2.4%) |
| Sept 2016 | - | -$24.97 M(-29.9%) | -$133.22 M(-8.3%) |
| June 2016 | - | -$35.62 M(-15.9%) | -$145.33 M(+3.1%) |
| Mar 2016 | - | -$42.35 M(+39.8%) | -$141.03 M(+5.2%) |
| Dec 2015 | -$134.02 M(+64.5%) | -$30.28 M(-18.3%) | -$134.02 M(-0.9%) |
| Sept 2015 | - | -$37.08 M(+18.4%) | -$135.19 M(+13.4%) |
| June 2015 | - | -$31.32 M(-11.4%) | -$119.23 M(+14.2%) |
| Mar 2015 | - | -$35.34 M(+12.3%) | -$104.44 M(+28.2%) |
| Dec 2014 | -$81.46 M(+102.2%) | -$31.46 M(+49.0%) | -$81.46 M(+35.1%) |
| Sept 2014 | - | -$21.11 M(+27.7%) | -$60.31 M(+28.5%) |
| June 2014 | - | -$16.54 M(+33.9%) | -$46.95 M(+15.9%) |
| Mar 2014 | - | -$12.35 M(+19.8%) | -$40.51 M(+0.6%) |
| Dec 2013 | -$40.28 M(-9.5%) | -$10.31 M(+33.1%) | -$40.28 M(-1.0%) |
| Sept 2013 | - | -$7.75 M(-23.2%) | -$40.70 M(-5.9%) |
| June 2013 | - | -$10.10 M(-16.7%) | -$43.26 M(-4.8%) |
| Mar 2013 | - | -$12.12 M(+13.0%) | -$45.44 M(+2.1%) |
| Dec 2012 | -$44.52 M | -$10.73 M(+4.0%) | -$44.52 M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$10.32 M(-16.0%) | -$42.62 M(+7.9%) |
| June 2012 | - | -$12.28 M(+9.6%) | -$39.49 M(+18.9%) |
| Mar 2012 | - | -$11.20 M(+27.0%) | -$33.21 M(+20.9%) |
| Dec 2011 | -$27.46 M(+104.3%) | -$8.82 M(+22.7%) | -$27.46 M(+20.3%) |
| Sept 2011 | - | -$7.19 M(+19.9%) | -$22.83 M(+17.6%) |
| June 2011 | - | -$6.00 M(+10.0%) | -$19.42 M(+21.2%) |
| Mar 2011 | - | -$5.45 M(+30.1%) | -$16.03 M(+19.2%) |
| Dec 2010 | -$13.44 M(+6.3%) | -$4.19 M(+10.8%) | -$13.44 M(+7.6%) |
| Sept 2010 | - | -$3.78 M(+45.3%) | -$12.49 M(+21.1%) |
| June 2010 | - | -$2.60 M(-9.2%) | -$10.32 M(+21.3%) |
| Mar 2010 | - | -$2.87 M(-11.5%) | -$8.51 M(-32.7%) |
| Dec 2009 | -$12.64 M(+59.9%) | -$3.24 M(+101.9%) | -$12.64 M(+17.0%) |
| Sept 2009 | - | -$1.60 M(+102.1%) | -$10.81 M(-1.4%) |
| June 2009 | - | -$794.00 K(-88.7%) | -$10.96 M(-7.5%) |
| Mar 2009 | - | -$7.00 M(+397.2%) | -$11.85 M(+49.9%) |
| Dec 2008 | -$7.90 M(-9.8%) | -$1.41 M(-19.8%) | -$7.90 M(-10.8%) |
| Sept 2008 | - | -$1.76 M(+4.1%) | -$8.86 M(-5.7%) |
| June 2008 | - | -$1.69 M(-44.7%) | -$9.39 M(+0.8%) |
| Mar 2008 | - | -$3.05 M(+29.3%) | -$9.31 M(+6.2%) |
| Dec 2007 | -$8.77 M(-27.9%) | -$2.36 M(+3.3%) | -$8.77 M(-1.6%) |
| Sept 2007 | - | -$2.29 M(+42.2%) | -$8.91 M(-4.2%) |
| June 2007 | - | -$1.61 M(-35.9%) | -$9.30 M(-10.3%) |
| Mar 2007 | - | -$2.51 M(+0.3%) | -$10.37 M(-14.7%) |
| Dec 2006 | -$12.15 M(-24.0%) | -$2.50 M(-6.6%) | -$12.15 M(-4.3%) |
| Sept 2006 | - | -$2.68 M(-0.0%) | -$12.71 M(-4.9%) |
| June 2006 | - | -$2.68 M(-37.5%) | -$13.37 M(-6.6%) |
| Mar 2006 | - | -$4.29 M(+40.5%) | -$14.31 M(-10.4%) |
| Dec 2005 | -$15.98 M(-23.6%) | -$3.05 M(-8.5%) | -$15.98 M(-10.0%) |
| Sept 2005 | - | -$3.34 M(-8.0%) | -$17.77 M(-8.7%) |
| June 2005 | - | -$3.63 M(-39.1%) | -$19.45 M(-7.4%) |
| Mar 2005 | - | -$5.96 M(+23.2%) | -$21.00 M(+0.4%) |
| Dec 2004 | -$20.91 M(+50.8%) | -$4.84 M(-3.8%) | -$20.91 M(-9.2%) |
| Sept 2004 | - | -$5.03 M(-2.9%) | -$23.02 M(+142.3%) |
| June 2004 | - | -$5.18 M(-11.6%) | -$9.50 M(-16.1%) |
| Mar 2004 | - | -$5.86 M(-15.6%) | -$11.33 M(-18.3%) |
| Dec 2003 | -$13.87 M(+16.4%) | -$6.95 M(-181.8%) | -$13.87 M(-0.5%) |
| Sept 2003 | - | $8.49 M(-221.1%) | -$13.94 M(-52.2%) |
| June 2003 | - | -$7.01 M(-16.6%) | -$29.18 M(+111.6%) |
| Mar 2003 | - | -$8.40 M(+19.8%) | -$13.79 M(+15.7%) |
| Dec 2002 | -$11.92 M(-24.8%) | -$7.02 M(+3.9%) | -$11.92 M(+37.2%) |
| Sept 2002 | - | -$6.75 M(-180.6%) | -$8.68 M(+41.3%) |
| June 2002 | - | $8.38 M(-228.3%) | -$6.15 M(-66.8%) |
| Mar 2002 | - | -$6.53 M(+72.6%) | -$18.50 M(+16.8%) |
| Dec 2001 | -$15.84 M(+98.2%) | -$3.78 M(-10.3%) | -$15.84 M(+31.4%) |
| Sept 2001 | - | -$4.21 M(+6.0%) | -$12.05 M(+53.7%) |
| June 2001 | - | -$3.97 M(+2.8%) | -$7.84 M(+102.8%) |
| Mar 2001 | - | -$3.87 M | -$3.87 M |
| Dec 2000 | -$7.99 M(+73.4%) | - | - |
| Dec 1999 | -$4.61 M | - | - |
FAQ
- What is Exact Sciences annual cash flow from operations?
- What is the all time high annual CFO for Exact Sciences?
- What is Exact Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Exact Sciences?
- What is Exact Sciences quarterly CFO year-on-year change?
- What is Exact Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Exact Sciences?
- What is Exact Sciences TTM CFO year-on-year change?
What is Exact Sciences annual cash flow from operations?
The current annual CFO of EXAS is $156.12 M
What is the all time high annual CFO for Exact Sciences?
Exact Sciences all-time high annual cash flow from operations is $156.12 M
What is Exact Sciences quarterly cash flow from operations?
The current quarterly CFO of EXAS is $138.72 M
What is the all time high quarterly CFO for Exact Sciences?
Exact Sciences all-time high quarterly cash flow from operations is $138.72 M
What is Exact Sciences quarterly CFO year-on-year change?
Over the past year, EXAS quarterly cash flow from operations has changed by +$69.17 M (+99.46%)
What is Exact Sciences TTM cash flow from operations?
The current TTM CFO of EXAS is $233.02 M
What is the all time high TTM CFO for Exact Sciences?
Exact Sciences all-time high TTM cash flow from operations is $233.02 M
What is Exact Sciences TTM CFO year-on-year change?
Over the past year, EXAS TTM cash flow from operations has changed by +$76.90 M (+49.26%)